Despite research showing that adverse reactions to the epilepsy drug Carbamazepine are highly frequent, patients who have such reactions will not qualify for the Department of Health’s (DOH) drug relief program because the drug is mainly prescribed by doctors for “off-label” use, Democratic Progressive Party (DPP) Legislator Huang Sue-ying (黃淑英) said yesterday.
At a press conference yesterday, Huang cited the case of a man, surnamed Hsu (徐), who had experienced an adverse reaction to the drug but could not receive drug relief compensation, saying that this highlighted a serious problem caused by the failure of the health authorities to provide the public with protection against drugs that were prescribed off-label.
Doctors may legally prescribe drugs off-label if the drug is safe to use and found to be effective in treating a certain condition that it has not yet been approved for. For example, Carbamazepine, which has been officially approved for use in treating epilepsy, is also often prescribed by doctors as a mood stabilizer or pain reliever.
“While it is legal for doctors to prescribe drugs off-label, patients who follow their doctor’s instructions to take the drug cannot receive any help or compensation if they have an adverse reaction because the DOH’s drug relief program then deems off-label use illegal, which is unreasonable,” Huang said.
Huang cited statistics from the Drug Relief Foundation, which showed that from 2005 until last year, there were 299 cases of patients who had adverse reactions to drugs but could not receive compensation. Of the 299 cases, 101 (34 percent) were patients who used off-label drugs.
She also cited a research study by Academia Sinica in April 2004 that showed as many as 5 percent of people in Taiwan carry a gene that has shown to increase the risk of developing Stevens Johnson syndrome as a reaction to taking Carbamazepine. As a result, compared with the relatively low rate of white Caucasians who carry this gene, Taiwanese are 30 times more at risk of developing the syndrome in reaction to the drug.
Huang urged DOH officials to re-evaluate whether Carbamazepine should be legally approved as safe for use in the country, as well as provide drug relief for patients who suffer from adverse drug reactions as a result of off-label use.
Hsu Chien-wen (喋??, deputy director of the Food and Drug Administration’s division of drug and new biotechnology products, said that as no drug is 100 percent safe, doctors are advised to continue monitoring patients’ progress while they are taking them.
She said DOH officials would invite experts to discuss drug relief assistance and compensation.
Hong Kong singer Eason Chan’s (陳奕迅) concerts in Kaohsiung this weekend have been postponed after he was diagnosed with Covid-19 this morning, the organizer said today. Chan’s “FEAR and DREAMS” concert which was scheduled to be held in the coming three days at the Kaohsiung Arena would be rescheduled to May 29, 30 and 31, while the three shows scheduled over the next weekend, from May 23 to 25, would be held as usual, Universal Music said in a statement. Ticket holders can apply for a full refund or attend the postponed concerts with the same seating, the organizer said. Refund arrangements would
Taiwanese indie band Sunset Rollercoaster and South Korean outfit Hyukoh collectively received the most nominations at this year’s Golden Melody Awards, earning a total of seven nods from the jury on Wednesday. The bands collaborated on their 2024 album AAA, which received nominations for best band, best album producer, best album design and best vocal album recording. “Young Man,” a single from the album, earned nominations for song of the year and best music video, while another track, “Antenna,” also received a best music video nomination. Late Hong Kong-American singer Khalil Fong (方大同) was named the jury award winner for his 2024 album
Palauan President Surangel Whipps Jr arrived in Taiwan last night to kick off his first visit to the country since beginning his second term earlier this year. After arriving at Taoyuan International Airport at around 6:30 pm, Whipps and his delegation were welcomed by Minister of Foreign Affairs Lin Chia-lung (林佳龍). Speaking to gathered media, the Palauan leader said he was excited and honored to be back in Taiwan on his first state visit to Taiwan since he was sworn in this January. Among those traveling with Whipps is Minister of State Gustav N. Aitaro, Public Infrastructure
Premier Cho Jung-tai (卓榮泰) on Friday laid out the Cabinet’s updated policy agenda and recapped the government’s achievements ahead of the one-year anniversary of President William Lai’s (賴清德) inauguration. Cho said the government had made progress across a range of areas, including rebuilding Hualien, cracking down on fraud, improving pedestrian safety and promoting economic growth. “I hope the public will not have the impression that the Cabinet only asked the legislature to reconsider a bunch of legal amendments,” Cho said, calling the moves “necessary” to protect constitutional governance and the public’s interest. The Cabinet would work toward achieving its “1+7” plan, he said. The